Supramolecular tadalafil nanovaccine for cancer immunotherapy by alleviating myeloid‐derived suppressor cells and heightening immunogenicity(A23220-9.1)
Supramolecular tadalafil nanovaccine for cancer immunotherapy by alleviating myeloid‐derived suppressor cells and heightening immunogenicity(A23220-9.1)